You are here:

NICE
NICE Guidance
Conditions and diseases
Cancer
Head and neck cancers

Head and neck cancers Products

A list of all our products on head and neck cancers

Filter

Product type
1 selected

Product typeGuidanceQuality standards

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceInterventional procedures guidance

Status

StatusPublishedIn developmentAwaiting developmentTopic selection

New and updated
1 selected

New and updatedNew in the last 6 months

Showing 1 product

Sort by: Date | Sort by Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Pembrolizumab for neoadjuvant and with radiotherapy for adjuvant treatment of newly diagnosed resectable locally advanced squamous cell head and neck cancer [ID6477]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC